Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,704 | 16,588 | 13,698 | 17,889 | 9,357 |
| Receivables | 17,589 | 16,632 | 17,559 | 17,171 | 15,724 |
| Inventories | 15,832 | 14,406 | 11,901 | 14,983 | 10,743 |
| Income taxes - deferred | 5,441 | 573 | 306 | N/A | 149 |
| Other current assets | 0 | 0 | 0 | 4,268 | 17,312 |
| TOTAL | $58,566 | $48,199 | $43,464 | $54,311 | $53,285 |
| Non-Current Assets | |||||
| PPE Net | 3,146 | 3,545 | 3,221 | 4,465 | 4,610 |
| Intangibles | 56,600 | 54,513 | 33,782 | 10,640 | 10,457 |
| Other Non-Current Assets | 6,485 | 974 | 804 | 29,437 | 24,876 |
| TOTAL | $66,231 | $59,032 | $37,807 | $44,542 | $39,943 |
| Total Assets | $124,797 | $107,231 | $81,271 | $98,853 | $93,228 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,925 | 4,856 | 4,665 | 5,611 | 4,490 |
| Accrued Expenses | 5,271 | 4,049 | 4,433 | 5,220 | 4,439 |
| Other current liabilities | 649 | 2,906 | 167 | 1,128 | 451 |
| TOTAL | $11,296 | $12,258 | $11,215 | $16,341 | $14,684 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,009 | 13,308 | 59 | 5,578 | 3,000 |
| Deferred Revenues | 451 | 434 | 589 | 442 | 238 |
| Other Non-Current Liabilities | 4,290 | 4,371 | 2,063 | 1,237 | 2,319 |
| TOTAL | $23,253 | $19,716 | $3,338 | $8,375 | $6,661 |
| Total Liabilities | $34,549 | $31,974 | $14,553 | $24,716 | $21,345 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,839 | 2,958 | 2,993 | 3,086 | 3,057 |
| Common Shares | 361 | 360 | 358 | 355 | 352 |
| Retained earnings | -83,442 | -102,457 | -109,690 | -111,363 | -110,009 |
| Other shareholders' equity | -3,564 | -1,502 | -3,023 | 6,992 | 6,506 |
| TOTAL | $90,248 | $75,257 | $66,718 | $74,137 | $71,883 |
| Total Liabilities And Equity | $124,797 | $107,231 | $81,271 | $98,853 | $93,228 |